Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 102 entries
View as:

A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)

Phase: N/A Priority: Normal
NCT ID: NCT04893785 Org: User:
Start: 06/15/21 End: 12/31/26 Due: 12/31/27

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00326456 Org: User:
Start: 01/01/03 End: 12/31/23 Due: 12/31/24

Pathway to Diagnosis of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01061619 Org: User:
Start: 01/31/10 End: 11/30/24 Due: 11/30/25

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00385606 Org: User:
Start: 01/31/03 End: 07/31/06 Due: 07/31/07

Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)

Phase: N/A Priority: Normal
NCT ID: NCT06884878 Org: User:
Start: 10/08/24 End: 11/30/26 Due: 11/30/27

G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT00401609 Org: User:
Start: 11/30/00 End: 02/28/09 Due: 02/28/10

Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT03891485 Org: User:
Start: 12/31/16 End: 08/30/23 Due: 08/30/24

Validation of the Italian Version of the PRO-CTCAE

Phase: N/A Priority: Normal
NCT ID: NCT04416672 Org: User:
Start: 07/01/18 End: 07/31/24 Due: 07/31/25

Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)

Phase: N/A Priority: Normal
NCT ID: NCT04893356 Org: User:
Start: 01/20/21 End: 01/20/25 Due: 01/20/26

The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.

Phase: N/A Priority: Normal
NCT ID: NCT06866093 Org: User:
Start: 09/04/23 End: 12/31/26 Due: 12/31/27

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04425239 Org: User:
Start: 05/21/18 End: 04/03/22 Due: 04/03/23

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02035683 Org: User:
Start: 10/31/13 End: 12/31/24 Due: 12/31/25

Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01898104 Org: User:
Start: 05/31/12 End: 04/30/24 Due: 04/30/25

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00412022 Org: User:
Start: 03/31/04 End: 11/30/24 Due: 11/30/25

Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01644825 Org: User:
Start: 12/31/10 End: 12/29/15 Due: 12/29/16

PRO for Fighting FT in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06032975 Org: User:
Start: 10/30/23 End: 09/01/27 Due: 09/01/28

MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05255471 Org: User:
Start: 01/21/22 End: 01/21/28 Due: 01/21/29

Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma

Phase: N/A Priority: Normal
NCT ID: NCT06341764 Org: User:
Start: 09/01/23 End: 09/30/25 Due: 09/30/26

Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy

Phase: N/A Priority: Normal
NCT ID: NCT03473379 Org: User:
Start: 03/01/18 End: 07/01/24 Due: 07/01/25

Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01651026 Org: User:
Start: 01/31/11 End: 12/31/24 Due: 12/31/25

Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02624128 Org: User:
Start: 02/23/15 End: 12/31/23 Due: 12/31/24

MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00401492 Org: User:
Start: 06/30/02 End: 04/30/07 Due: 04/30/08

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02618850 Org: User:
Start: 04/30/14 End: 12/31/24 Due: 12/31/25

Diet, Exercise and Vitamin D in Breast Cancer Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT02786875 Org: User:
Start: 11/04/16 End: 12/15/23 Due: 12/15/24

Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00660842 Org: User:
Start: 11/30/08 End: 11/30/24 Due: 11/30/25